Prevalence of autoreactive antibodies (ARAB) in patiens with relapsing-remitting multiple sclerosis (RRMS) under interferon beta treatment

被引：0
|
作者：
Papastergios, C. [1 ]
Karamouzos, E. [1 ]
Markakis, I. [1 ]
Kaliouli, C. [2 ]
Pappa, E. [2 ]
Gekas, G. [1 ]
机构：
[1] St Panteleimon Gen State Hosp Piraeus, Neurol, Piraeus, Greece
[2] St Panteleimon Gen State Hosp Piraeus, Immunol, Athens, Greece
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3169
引用
收藏
页码：360 / 360
页数：1
相关论文
共 50 条
  • [1] Interferon beta 1a treatment induces the presence of autoreactive antibodies (ARAB) in patients with relapsing-remitting multiple sclerosis (RRMS)
    Papastergios, Chrysostomos
    Karamouzos, Emmanouil
    Markakis, Ioannis
    Kaliouli, Christiana
    Eleni, Pappa
    Gekas, Georgios
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 167 - 167
  • [2] The effect of interferon beta (IFNB) on location of relapsing-remitting multiple sclerosis (RRMS) relapse
    Deen, Serina
    High, Andrew
    Waubaunt, Emmanuelle
    [J]. ANNALS OF NEUROLOGY, 2007, 62 : S14 - S14
  • [3] The use of interferon beta in relapsing-remitting multiple sclerosis
    Etheridge, LJ
    Beverley, DW
    Ferrie, C
    McManus, E
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) : 789 - 791
  • [4] Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
    Cocco, Eleonora
    Marrosu, Maria Giovanna
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 759 - 766
  • [5] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    [J]. PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [6] REGIONAL EFFICACY OF NATALIZUMAB TREATMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
    Doshi, Anisha
    Voysey, Zanna
    Bunting, Eva
    Malik, Muzaffar
    Rashid, Waqar
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [7] Clinical significance of antibodies to interferon beta therapy in patients with relapsing-remitting multiple sclerosis
    Bendtzen, Klaus
    [J]. CYTOKINE, 2009, 48 (1-2) : 21 - 21
  • [8] Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
    Etemadifar, Masoud
    Janghorbani, Mohsen
    Shaygannejad, Vahid
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (12) : 1723 - 1728
  • [9] Interferon beta-1a in relapsing-remitting multiple sclerosis
    Blumhardt, L
    [J]. HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
  • [10] Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis
    M. Etemadifar
    M. Janghorbani
    V. Shaygannejad
    [J]. Journal of Neurology, 2007, 254
12345